Towards Healthcare
Middle East and Africa Clinical Trials Market to Gain USD 7.36 Bn by 2034

Middle East and Africa Clinical Trials Market Expanding Research Investments

Market insights predict, the Middle East and Africa clinical trials industry is expected to grow from USD 3.81 billion in 2024 to USD 7.36 billion by 2034, driven by a CAGR of 6.80%. The rising prevalence of chronic and lifestyle diseases such as diabetes, cardiovascular disorders, and cancer increases demand for new drugs and therapies has driven the growth of the market in the near future. South Africa led the global market owing to a well-established healthcare infrastructure and an experienced clinical research workforce in the region.

Content

  • Insight Code: 6294
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The Middle East and Africa clinical trials market is worth USD 4.07 billion in 2025, and by 2034, it is forecasted to hit USD 7.36 billion, registering a CAGR of 6.80% over the decade.

South Africa is leading the Middle East and Africa clinical trials market due to the strong institutions for vaccine development, growing prevalence of oncology and diabetes, as well as the presence of advanced healthcare infrastructure.

The Middle East and Africa clinical trials market includes four segments including by phase, by study design, by indication, and by country/geography.

Key trends include the digital and decentralized clinical trials, adoption of inorganic growth strategies like collaboration, Emphasis on Patient-Centric Approaches, and increased focus on rare and chronic diseases.

Federation of African Societies of Biochemistry and Molecular Biology (FASBMB), International Centre for Genetic Engineering and Biotechnology (ICGEB), Biopharma Middle East & Africa, clinicaltrials.gov, CardioVascular Clinical Trialists Middle East, WHO, Mediterranean and Africa (CVCT-MEMA), JAMA, Clinical Trial Community Africa Network (CTCAN), Clinical Trials Community Africa Network (CTCAN), and Middle East & Africa Conference (MEA), among others.
Any Questions